A Sequential Dose-Escalation Study in Subjects With Mild Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions
Asthma
Interventions
BIOLOGICAL

MEDI-563

"BIW-8405/MEDI-563 administered at one of five dose levels:~* 0.03 mg/kg intravenous injection~* 0.1 mg/kg intravenous injection~* 0.3 mg/kg intravenous injection~* 1.0 mg/kg intravenous injection~* 3.0 mg/kg intravenous injection~Following the -3.0 mg/kg dose level,~BIW-8405/MEDI-563 administered at one of two lower dose levels:~0.003 mg/kg intravenous injection 0.0003 mg/kg intravenous injection"

Trial Locations (3)

53792

Allergy-Asthma-K4, Madison

80206

Jewish Medical and Research Center, Denver

02747

Northeast Medical Research Associates, Inc., North Darthmouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MedImmune LLC

INDUSTRY